US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
TRACKER FUND
ISHARES A50
HSCEI ETF
CSOP A50 ETF
CAM CSI300
Last (HKD)1
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
ETF Overview
Issuer
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
TRACKER FUND
Hang Seng Index 23.140
HKD
-0.380 -1.616% 602.69M 13.96B 23.512 (-1.583%)
HKD as at 2025/04/02
HSCEI ETF
Hang Seng China Enterprises 85.960
HKD
-1.300 -1.490% 154.82M 13.31B 87.316 (-1.553%)
HKD as at 2025/04/01
CSOP HS TECH
Hang Seng TECH Index 5.190
HKD
-0.120 -2.260% 674.66M 3.52B 5.292 (-1.931%)
HKD as at 2025/04/01
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng TECH Index 5.510
HKD
-0.260 -4.506% 250.53M 1.39B 5.753 (-4.227%)
HKD as at 2025/04/01
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng TECH Index 2.000
HKD
+0.088 +4.603% 635.51M 1.26B 1.925 (+3.880%)
HKD as at 2025/04/01
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng Index 2.712
HKD
+0.092 +3.511% 180.27M 488.96M 2.614 (+3.769%)
HKD as at 2025/04/01
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng Index 4.844
HKD
-0.166 -3.313% 43.70M 211.77M 5.032 (-3.738%)
HKD as at 2025/04/01
ISHARESHSTECH
Hang Seng TECH Index 11.110
HKD
-0.290 -2.544% 17.53M 195.33M 11.335 (-1.986%)
HKD as at 2025/04/01
HSTECH ETF
Hang Seng TECH Index 5.265
HKD
-0.125 -2.319% 22.63M 119.29M 5.368 (-1.915%)
HKD as at 2025/04/01
CAM CSI300
CSI 300 42.400
HKD
-0.440 -1.027% 1.86M 78.99M 42.964 (-1.312%)
HKD as at 2025/04/01
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
NASDAQ-100 Index 6.175
HKD
+0.245 +4.132% 8.19M 50.65M 5.884 (+4.955%)
HKD as at 2025/04/01
A GX HSCEICC
Hang Seng China Enterprises 10.560
HKD
-0.110 -1.031% 4.00M 42.24M 10.627 (-0.626%)
HKD as at 2025/04/01
SPDR GOLD TRT
London Gold Fixing Price 2,261.000
HKD
+21.000 +0.938% 16.01K 36.24M N/A
CSOP A50 ETF
FTSE China A50 12.610
HKD
-0.070 -0.552% 2.69M 33.85M 12.733 (-0.964%)
HKD as at 2025/04/01
ISHARES A50
FTSE China A50 13.490
HKD
-0.090 -0.663% 2.40M 32.42M 13.629 (-1.021%)
HKD as at 2025/04/01
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Solactive Gold 1-Day Rolling Futures Index 15.690
HKD
+0.170 +1.095% 1.11M 17.46M 15.452 (+1.538%)
HKD as at 2025/04/01
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng China Enterprises 3.124
HKD
-0.104 -3.222% 4.46M 13.95M 3.251 (-3.892%)
HKD as at 2025/04/01
FI2 CSOP NIKKEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Nikkei Stock Average Index 81.120
HKD
+6.120 +8.160% 155.29K 12.45M 75.199 (+7.874%)
HKD as at 2025/04/01
PING AN HKDIV
CSI Hong Kong Dividend 33.340
HKD
-0.420 -1.244% 351.50K 11.67M 33.730 (-1.157%)
HKD as at 2025/04/01
FI CSOP HSI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng Index 4.106
HKD
+0.068 +1.684% 2.23M 9.15M 4.030 (+1.893%)
HKD as at 2025/04/01
GX HS HIGH DIV
Hang Seng High Dividend Yield 24.900
HKD
-0.180 -0.718% 328.00K 8.17M 24.934 (-0.136%)
HKD as at 2025/04/01
FL2CSOPNASDAQ
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
NASDAQ-100 Index 19.860
HKD
-0.920 -4.427% 405.00K 8.03M 20.948 (-5.192%)
HKD as at 2025/04/01
ISHARESHSI
Hang Seng Index (net total return version) 83.260
HKD
-1.420 -1.677% 96.27K 8.02M 84.524 (-1.495%)
HKD as at 2025/04/01
XL2 BOS CHINEXT
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
ChiNext Index (HKD)(CNH) 3.460
HKD
-0.140 -3.889% 2.07M 7.26M 3.614 (-4.269%)
HKD as at 2025/04/01
CSOP HEALTHCARE
Solactive China Healthcare Disruption Index 2.478
HKD
-0.032 -1.275% 2.82M 6.97M 2.507 (-1.153%)
HKD as at 2025/04/01
XL2CSOPCSI300
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
CSI 300 3.530
HKD
-0.060 -1.671% 1.96M 6.94M 3.641 (-3.057%)
HKD as at 2025/04/01
FI2 CSOP HSCEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng China Enterprises 2.026
HKD
+0.068 +3.473% 3.31M 6.70M 1.947 (+4.041%)
HKD as at 2025/04/01
CAM HSI ESG
HSI ESG Enhanced Index (net total return index) 47.120
HKD
-0.940 -1.956% 135.69K 6.37M 47.881 (-1.589%)
HKD as at 2025/04/01
TRACKER FUND-R
Hang Seng Index 21.700
CNY
-0.280 -1.274% 269.50K 5.87M 21.996 (-1.343%)
CNY as at 2025/04/02
CSOP UST20
FTSE US Treasury 20+ Years Index 72.900
HKD
+1.060 +1.476% 80.23K 5.83M 71.861 (+1.447%)
HKD as at 2025/04/01
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2025/04/03 12:40
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1

2

Compare